Back
AbbVie Vs. Tandem Diabetes Care Industry Stock Comparison
Sell
48
ABBV
AbbVie
Last Price:
159.59
Seasonality Move:
2.71%
Buy
57
TNDM
Tandem Diabetes Care
Last Price:
35.25
Seasonality Move:
19.79%
Sell
48
AbbVie (ABBV)
is a Sell
Is AbbVie a Buy, Sell or Hold?
- The current AbbVie [ABBV] share price is $167.29. The Score for ABBV is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- ABBV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Tandem Diabetes Care (TNDM)
is a Buy
Is Tandem Diabetes Care a Buy, Sell or Hold?
- The current Tandem Diabetes Care [TNDM] share price is $35.56. The Score for TNDM is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- TNDM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ABBV Stock Price Chart
TNDM Stock Price Chart
What is Tandem Diabetes Care's stock price today?
-
The Tandem Diabetes Care share price today is $35.56
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TNDM is experiencing slight selling pressure.
ABBV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.41 | Sell |
| Relative Strength Index (14 RSI): | 43 | Sell |
| Chaikin Money Flow: | -409994 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (164.81 - 177.87) | Sell |
| Bollinger Bands (100): | (157.22 - 177.76) | Sell |
TNDM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.85 | Buy |
| Relative Strength Index (14 RSI): | 61.4 | Buy |
| Chaikin Money Flow: | -69164 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.58 - 34.88) | Buy |
| Bollinger Bands (100): | (23.93 - 32.01) | Buy |
ABBV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 166.3 | Buy |
| 20-day SMA: | 169.48 | Sell |
| 50-day SMA: | 174.78 | Sell |
| 200-day SMA: | 156.69 | Buy |
| 8-day EMA: | 167.21 | Buy |
| 20-day EMA: | 169.15 | Sell |
| 50-day EMA: | 170.8 | Sell |
| 200-day EMA: | 160.73 | Buy |
TNDM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.93 | Buy |
| 20-day SMA: | 33.48 | Buy |
| 50-day SMA: | 30.52 | Buy |
| 200-day SMA: | 25.78 | Buy |
| 8-day EMA: | 33.72 | Buy |
| 20-day EMA: | 32.98 | Buy |
| 50-day EMA: | 30.9 | Buy |
| 200-day EMA: | 28.99 | Buy |
AbbVie Earnings Growth & ABBV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.20 per share, an increase this year of $0.05 per share, and an increase next year of $0.93 per share.
Tandem Diabetes Care Earnings Growth & TNDM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.28 per share, an increase this year of $0.20 per share, and an increase next year of $0.53 per share.
AbbVie Technical Analysis
| Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Tandem Diabetes Care Technical Analysis
| Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||